Navigation Links
Former NxStage System One User Celebrates One-Year Kidney Transplant Anniversary
Date:8/29/2011

LAWRENCE, Mass., Aug. 29, 2011 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that former NxStage® System One™ patient Tederra Coleman is celebrating the one-year anniversary of her successful kidney transplant. Coleman, 33, of Pompano Beach, Florida, received her transplant after experiencing two years of daily home hemodialysis with the NxStage System One™. Prior to beginning daily home hemodialysis, Coleman spent seven years undergoing thrice-weekly treatments at a dialysis center.

(Logo:  http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)

More frequent dialysis with the System One resulted in such a positive change in Coleman's health and quality of life, that she became a certified hemodialysis technician. Her goal is to inform patients about their therapy options, including home hemodialysis with the System One so they can experience the benefits possible with this life changing therapy.  

"As an in-center dialysis patient, I didn't like going to the center and the strict schedule was difficult to keep with my job, so I often skipped my treatments, putting my health in jeopardy," said Coleman. "It was my desire to dialyze at home that motivated me to become a compliant patient. Once I began using the System One, I finally felt in control of my life and health and managed my dialysis care properly, which allowed me to become a transplant candidate."

"Recent objective clinical data from large, well designed trials have proven that more frequent hemodialysis with the System One has a positive impact on patient survival, clinical outcomes and quality of life," stated Jeffrey H. Burbank, Chief Executive Officer of NxStage Medical. "We're pleased to celebrate with Tederra
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
2. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
3. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
4. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
5. Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
6. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
7. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
8. Former Miss USA Shawnae Jebbia Shines with Siemens Pure
9. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
10. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
11. SCAI Statement on the Hospitalization of Former President Bill Clinton
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/19/2014)... October 19, 2014 Große ... Das Problem dabei ist, dass große Pharmafirmen ... Kompetenz zu teilen. Es war deshalb ... wir uns umso mehr, dass es uns gelungen ... bei Kühlketten aufzuschreiben - mit einem Vorbehalt - ...
(Date:10/17/2014)... , Oct. 17, 2014  Training market ... a critical success factor in today,s highly competitive ... market research organizations that effectively and efficiently produce ... or service area. Effective training ... and earn recognition from internal clients by developing ...
(Date:10/17/2014)... , Oct. 17, 2014 UBM Medica US ... a leading online community and information resource for neurologists and ... and Alzheimer disease , with discussions of the ... 1 million Americans have Parkinson disease , more than ... or Lou Gehrig disease. Diagnosis can be difficult ...
Breaking Medicine Technology:Vergleichsbericht zu Pharma-Kühlketten und CRT 2Effective Training Programs for Market Research Groups can Boost Overall Organizational Success 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3
... An optimized PARI eFlow,platform nebulizer will be ... trial that has begun enrolling patients. ALN-RSV01 is ... respiratory syncytial virus,(RSV) infection, the leading cause of ... in immune-compromised adults. RSV currently does,not have a ...
... SGP ), a leader in advancing the ... infection, announced today that final,results of the IDEAL ... studies,with PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP),combination ... for the,Study of the Liver (EASL) 43rd annual ...
Cached Medicine Technology:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 7Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 8Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting 9
(Date:10/20/2014)... 2014 The Advocator Group, LLC ... the American Foundation for Suicide Prevention’s (AFSP) Out of ... a not-for-profit organization that hosts hundreds of community walks ... events are used to help understand and prevent suicide ... relationships as well. , The Advocator Group shares ...
(Date:10/20/2014)... Indianapolis, IN (PRWEB) October 20, 2014 ... Quick Start, a secure cloud solution that enables ... advantage of the ultimate healthcare-specific customer relationship management ... to meet the unique needs of the healthcare ... healthcare experience for providers and patients by combining ...
(Date:10/20/2014)... 20, 2014 Principle Business Enterprises, a ... in manufacturing top-of-the-line absorbent products. The company has ... most popular brand, Tranquility® Premium Protection absorbent products. ... website, gave its packaging a new look, and is ... message to the public. , The new website, developed ...
(Date:10/20/2014)... 2014 Succeed is proud to announce that ... participated in the Every Body Walk! campaign by ... project that encourages workers to be more active outside of ... which concluded at the end of September, was a friendly ... metro areas. Participating companies gave their staff pedometers and ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, ... estimates member hospital ROI on membership dues at 12.5. In ... provides $12.50 in value to member hospitals. The calculation used ... Dues)/Member Dues. , “This is the first time we’ve ... think the methodology is really sound,” said Bill Ryan ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... and growth hormone expert from University Hospitals Rainbow Babies and ... New England Journal of Medicine commenting on a ... doses of estrogen, as well as growth hormone, years before ... benefits. With her co-author Dr. Robert L. Rosenfield, ...
... need to proactively engage lesbian, gay, bisexual, and transgender ... populations to identify and better understand health conditions that ... of Medicine. The scarcity of research yields an ... is further fragmented by the tendency to treat sexual ...
... life-threatening bloodstream infections in children with peripherally inserted central ... removing the device as early as possible, according to ... March 31 in the journal Clinical Infectious Diseases ... Saturday, April 2, at the annual meeting of the ...
... News) -- In an update to its ongoing radiation ... U.S. government officials announced late Wednesday that milk sampled ... radiation not likely to cause harm to humans. ... and Drug Administration and the Environmental Protection Agency, the ...
... field continues to grow. Following the successful First ... the Second International Conference on Immune Tolerance will ... research and insights into the mechanisms and treatment ... diseases, inflammation and cancer. This Conference is supported ...
... to a riddle or understand the solution to a problem, ... our head. But what happens after the ,Aha!, moment? Why ... stick in our memory? ,Much of memory research involves ... the group of Prof. Yadin Dudai of the Institute,s Neurobiology ...
Cached Medicine News:Health News:Assessing the value of treatments to increase height 2Health News:Researchers need to engage lesbian, gay, bisexual, and transginder populations in health studies 2Health News:Remove children's catheters as soon as possible to prevent bloodstream infections 2Health News:2nd International Conference on Immune Tolerance 2Health News:Getting a grasp on memory 2
... Farnsworth panel D15 test evaluation has ... to arrange caps with automatic creation ... manual color deficiency analysis, calculation of ... age-corrected CCI, eye selection (OD, OS, ...
... test is used to separate ... vs normal. Farnsworth D15 come ... the patient to select the ... box is closed and the ...
HRR/Amsler book combo with occluding glasses....
Ishihara test chart book for color blindness. 14 plate. A simple accurate method for discovering congenital color blindness....
Medicine Products: